Douglas MacDonald

Douglas Macdonald is a seasoned professional in the field of research operations and scientific alliances, currently serving as Director at CHDI Foundation since 2005, where responsibilities include managing resources for therapeutic development and focused research on huntingtin protein assays. Douglas holds positions as a member of the Dean’s Advisory Board at Boston University School of Medicine and the Executive Committee of the Board of Fellows at Trinity College-Hartford, providing strategic guidance and counsel. Additionally, Douglas contributes to the scientific community as a member of the Scientific Advisory Board for CureDuchenne and serves as a lecturer at the University of Southern California's Regulatory Sciences Program. With a solid academic background including a Ph.D. in Pharmacology from Boston University and a BS in Chemistry from Trinity College, Douglas has previously held roles at prominent organizations such as Aventis Pharmaceuticals and Schering-Plough Research Institute.